Kara Penne

1.1k total citations · 1 hit paper
11 papers, 691 citations indexed

About

Kara Penne is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kara Penne has authored 11 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kara Penne's work include Pancreatic and Hepatic Oncology Research (4 papers), Esophageal and GI Pathology (3 papers) and Clinical practice guidelines implementation (2 papers). Kara Penne is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Esophageal and GI Pathology (3 papers) and Clinical practice guidelines implementation (2 papers). Kara Penne collaborates with scholars based in United States and France. Kara Penne's co-authors include James E. Herndon, Jennifer A. Quinn, James J. Vredenburgh, Henry S. Friedman, Jeremy N. Rich, David A. Reardon, Darell D. Bigner, Allan H. Friedman, Jeannette M. Dowell and Carol J. Wikstrand and has published in prestigious journals such as Journal of Clinical Oncology, Neuro-Oncology and Journal of Surgical Research.

In The Last Decade

Kara Penne

11 papers receiving 671 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase II Trial of Gefitinib in Recurrent Glioblastoma

2003 558 citations Jeremy N. Rich, David A. Reardon et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kara Penne United States	7	375	260	256	203	154	11	691
Abhijit Ramachandran United States	11	247 0.7×	410 1.6×	131 0.5×	150 0.7×	49 0.3×	28	926
T Fujimoto Japan	11	370 1.0×	633 2.4×	185 0.7×	118 0.6×	90 0.6×	45	1.5k
Bertil Uggla Sweden	14	195 0.5×	485 1.9×	414 1.6×	95 0.5×	123 0.8×	31	1.1k
L. Pronk Netherlands	10	178 0.5×	83 0.3×	314 1.2×	187 0.9×	72 0.5×	20	557
Gilad W. Vainer Israel	14	82 0.2×	297 1.1×	257 1.0×	213 1.0×	245 1.6×	28	700
Budhi Singh Yadav India	13	82 0.2×	133 0.5×	240 0.9×	146 0.7×	272 1.8×	85	666
Gil Awada Belgium	15	132 0.4×	176 0.7×	450 1.8×	151 0.7×	100 0.6×	58	691
L Mangoni Italy	18	242 0.6×	231 0.9×	220 0.9×	75 0.4×	40 0.3×	53	886
Alicja Gruszka Italy	20	378 1.0×	395 1.5×	259 1.0×	60 0.3×	110 0.7×	36	945
M.T. Allende Spain	13	93 0.2×	184 0.7×	165 0.6×	150 0.7×	81 0.5×	25	589

Countries citing papers authored by Kara Penne

Since Specialization

Citations

This map shows the geographic impact of Kara Penne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kara Penne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kara Penne more than expected).

Fields of papers citing papers by Kara Penne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kara Penne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kara Penne. The network helps show where Kara Penne may publish in the future.

Co-authorship network of co-authors of Kara Penne

This figure shows the co-authorship network connecting the top 25 collaborators of Kara Penne. A scholar is included among the top collaborators of Kara Penne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kara Penne. Kara Penne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Gosselin, Tracy, et al.. (2015). The Role of the Advanced Practice Nurse in the Academic Setting. Seminars in Oncology Nursing. 31(4). 290–297. 3 indexed citations

2.

Nussbaum, Daniel P., Kara Penne, Paul J. Speicher, et al.. (2014). The role of clinical care pathways: an experience with distal pancreatectomy. Journal of Surgical Research. 190(1). 64–71. 12 indexed citations

3.

Nussbaum, Daniel P., Kara Penne, Sandra S. Stinnett, et al.. (2014). A standardized care plan is associated with shorter hospital length of stay in patients undergoing pancreaticoduodenectomy. Journal of Surgical Research. 193(1). 237–245. 43 indexed citations

4.

Nussbaum, Daniel P., Sabino Zani, Kara Penne, et al.. (2014). Feeding Jejunostomy Tube Placement in Patients Undergoing Pancreaticoduodenectomy: An Ongoing Dilemma. Journal of Gastrointestinal Surgery. 18(10). 1752–1759. 21 indexed citations

5.

Badruddoja, Michael, Kara Penne, Annick Desjardins, et al.. (2006). Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme1. Neuro-Oncology. 9(1). 70–74. 11 indexed citations

6.

Penne, Kara, et al.. (2005). Gefitinib (IressaTM, ZD1839) and Tyrosine Kinase Inhibitors. Cancer Nursing. 28(6). 481–486. 30 indexed citations

7.

Reardon, David A., Gamal Akabani, Allan H. Friedman, et al.. (2004). Results of a phase II trial with iodine 131-labeled murine antitenascin monoclonal antibody 81C6 (m81C6) via surgically created resection cavities in the treatment of patients with recurrent malignant brain tumors. 64. 1208–1208. 1 indexed citations

8.

Badruddoja, Michael, David A. Reardon, Gamal Akabani, et al.. (2004). Phase II trial of iodine 131-labeled murine anti-tenascin monoclonal anti-body 81C6 (M81C6) via surgically created resection cavity in the treatment of patients with recurrent malignant brain tumors. Journal of Clinical Oncology. 22(14_suppl). 1569–1569. 2 indexed citations

9.

Rich, Jeremy N., David A. Reardon, Jeannette M. Dowell, et al.. (2003). Phase II Trial of Gefitinib in Recurrent Glioblastoma. Journal of Clinical Oncology. 22(1). 133–142. 558 indexed citations breakdown →

10.

Richardson, Deborah & Kara Penne. (2003). Using Evidence in Central Catheter Care. Journal of the Association for Vascular Access. 8(4). 54–55. 1 indexed citations

11.

Penne, Kara. (2002). Using evidence in central catheter care. Seminars in Oncology Nursing. 18(1). 66–70. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact